Wall Street Experts
ver. ZuMIgo(08/25)
Denali Therapeutics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): -305
EBIT TTM (mln): -505
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
129 |
27 |
336 |
49 |
108 |
331 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
-79.3% |
1158.2% |
-85.5% |
122.9% |
204.7% |
-100.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
100.0% |
-624.9% |
36.7% |
88.5% |
93.5% |
94.9% |
0.0% |
EBIT (mln) |
-17 |
-87 |
-90 |
-46 |
-213 |
63 |
-296 |
-341 |
-197 |
-487 |
EBIT Δ r/r |
0.0% |
424.2% |
3.1% |
-48.6% |
359.7% |
-129.4% |
-571.6% |
15.2% |
-42.3% |
147.8% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-35.9% |
-799.1% |
18.7% |
-607.8% |
-314.2% |
-59.5% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
2 |
0 |
15 |
0 |
0 |
15 |
0 |
0 |
EBITDA (mln) |
-17 |
-86 |
-90 |
-46 |
-213 |
63 |
-296 |
-330 |
-180 |
-487 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-35.9% |
-799.1% |
18.7% |
-607.8% |
-304.6% |
-54.4% |
0.0% |
Podatek (mln) |
0 |
0 |
-3 |
10 |
-0 |
1 |
-1 |
0 |
0 |
-0 |
Zysk Netto (mln) |
-17 |
-87 |
-88 |
-36 |
-198 |
71 |
-291 |
-326 |
-145 |
-423 |
Zysk netto Δ r/r |
0.0% |
416.2% |
1.8% |
-58.9% |
445.3% |
-136.0% |
-508.5% |
12.2% |
-55.5% |
191.1% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-28.1% |
-740.7% |
21.2% |
-597.2% |
-300.6% |
-43.9% |
0.0% |
EPS |
-5.58 |
-13.49 |
-5.89 |
-0.39 |
-2.07 |
0.65 |
-2.39 |
-2.6 |
-1.06 |
-2.57 |
EPS (rozwodnione) |
-5.58 |
-13.49 |
-5.89 |
-0.39 |
-2.07 |
0.63 |
-2.39 |
-2.6 |
-1.06 |
-2.57 |
Ilośc akcji (mln) |
3 |
6 |
15 |
93 |
96 |
109 |
122 |
126 |
137 |
164 |
Ważona ilośc akcji (mln) |
3 |
6 |
15 |
93 |
96 |
113 |
122 |
126 |
137 |
164 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |